MIC1-matrix antigen 1 (MAG1) recombinant chimeric antigen can be effectively applied (sensitivity: 90.8%) instead of the Toxoplasma lysate antigen (sensitivity: 91.8%) for the serodiagnosis of human toxoplasmosis, exhibiting better results than a mixture of antigens. This evidence concerns the gene GPAT3 and toxoplasmosis.